Dallah Healthcare (4004) Stock: Price, GoFinsa Rating and News
GoFinsa provides a guide to Dallah Healthcare, listed under ticker 4004, with information about its economic sector and factors relevant to studying the stock.
About Dallah Healthcare and Its Business
Dallah Healthcare (ticker 4004) operates in the Saudi market and is described as manufacturing or distributing pharmaceutical products. The company description also lists hospitals, healthcare, pharmaceutical products and cosmetics among its areas of activity. This summary describes the stated nature of the business and products; it does not mean that all listed activities contribute equally to revenue or that they have produced any particular financial results.
Dallah Healthcare Stock Information
Dallah Healthcare shares trade on the Saudi Exchange under ticker 4004. The company belongs to the healthcare sector. Reviewing official disclosures and financial results can help investors understand the company’s position and the development of its business.
Dallah Healthcare’s Activities and Company Information
The company is classified within the healthcare sector in the Saudi market. Annual reports and official disclosures should be consulted to establish its activities, revenue sources and operating developments.
The Healthcare Sector in the Saudi Economy
The performance of listed healthcare companies can be affected by demand for their products and services, operating costs, competition, and economic and regulatory conditions. Each company’s exposure to these factors varies according to its business model.
How to Read the Stock’s Financial Results
It is important to compare revenue, profit, cash flow and debt across several financial periods, and to understand the reasons for changes rather than relying on a single quarter. Official announcements should also be reviewed for material events.
Factors That May Affect the Share Price
Dallah Healthcare’s share price may be influenced by company results and disclosures, Saudi market trends, interest rates and investor expectations. A change in the share price alone does not indicate an improvement in operating performance.
Investment Risks
Potential risks include share-price volatility, changes in costs, weaker demand, competition and regulatory changes. Actual risks depend on the company’s activities and financial position.
The Stock’s Investment Strength According to the GoFinsa Saudi Stocks Index
The recorded rating for the stock in the GoFinsa GFSI index is 75%. This is an independent analytical rating, not a guarantee of profit or a personal recommendation to buy.
Investing in Saudi Stocks
The Saudi market includes companies in a range of economic sectors. Investors may benefit from reviewing disclosures, comparing financial valuations, diversifying risk and setting an investment horizon before making a decision.
Following Company News
The latest disclosures and news relating to Dallah Healthcare can be followed through news sources and official data available on GoFinsa. Check the date of each item and how directly it relates to the company.
Dallah Healthcare’s Reference Price
The recorded reference price is 77.1 SAR as of 2026-10-08. This is a historical price, not a live quote or a confirmed price for current trading.
Dallah Healthcare’s Rating in the GoFinsa GFSI
The stock’s GoFinsa GFSI rating is 75%. This is GoFinsa’s research rating and is not a recommendation to buy or sell.
Overview of the Healthcare Sector
Dallah Healthcare belongs to the healthcare sector on the Saudi Exchange. Companies in the sector are affected by demand, competition, costs, and economic and regulatory conditions, while their risks and revenue sources vary.
Trading Through XTB and the Risks
What Does Dallah Healthcare Do?
Dallah Healthcare (4004) belongs to the healthcare sector. Potential activities identified for research include operating hospitals and medical centres and providing treatment services. Specific details and subsidiaries should be checked against the company’s latest official profile before publication.
Where Does Dallah Healthcare’s Revenue Come From?
When analysing Dallah Healthcare’s business model, review the following potential sources of income to the extent supported by the company’s financial statements: medical services revenue, visit volumes, occupancy and case mix. Listing these items does not mean they all make an actual contribution to the company’s revenue.
Factors That May Affect Dallah Healthcare’s Performance
Relevant indicators to monitor in relation to Dallah Healthcare’s activities include occupancy rates, expansion, staff costs and agreements with insurance companies. Compare actual trends in the company’s results across several periods, and do not infer growth or profitability without documented figures.
What to Check in the Annual Disclosure
When studying Dallah Healthcare (4004), first identify the date of the latest annual report, then review the description of actual activities, operating segments and revenue-recognition policy. Read the financial statement notes rather than relying only on management’s summary; the notes may disclose obligations or events not apparent from headline figures. Verify the listed entity’s name, subsidiaries and the nature of their operations before attributing any activity or project to the company. A trend in the healthcare sector is not evidence of revenue growth at this company unless its published results support that conclusion.
How to Distinguish Genuine Growth from Accounting Changes
To analyse Dallah Healthcare, compare several periods of the same duration and take note of non-recurring items, reclassifications and changes in the consolidation scope. Higher revenue does not necessarily mean improved profitability if the cost of sales or expenses have risen faster. Examine operating and net profit margins, then look for explanations in the management discussion and financial statement notes. Without reliable, up-to-date financial statements, these remain analytical steps rather than a description of Dallah Healthcare’s actual performance.
Cash Flow and the Capacity to Fund Operations
When reviewing Dallah Healthcare’s financial data, it is useful to distinguish accounting profit from cash generated by operations. Examine net operating cash flow, changes in working capital, capital expenditure and financing costs. A company may report profits while operating cash declines because of higher receivables, inventory or project payments. Conversely, cash flow may be temporarily affected by the timing of collections and payments. The company’s liquidity or solvency cannot be assessed without the relevant financial statements and notes.
Debt and Financing Costs: Key Questions
If Dallah Healthcare has financing obligations, start by identifying their maturity dates, the split between short- and long-term debt, borrowing costs and any contractual covenants. Assess how sensitive earnings and cash flow may be to changes in interest rates, taking into account whether financing arrangements carry fixed or variable rates. The relevance of these questions varies with the company’s healthcare business model. This guide does not assume that the company has any particular level of debt or risk.
Comparing the Stock with Sector Peers Without Misleading Conclusions
For a fair comparison of Dallah Healthcare, select companies with similar activities, revenue mix, scale and regulatory environments. Compare revenue growth, margins, return on capital and cash flow, then consider differences in accounting and leverage. A lower price-to-earnings multiple than that of another company is not, by itself, enough to conclude that the stock is cheaper; the difference may reflect growth expectations, risk or earnings quality. If a company has losses or non-recurring profits, some valuation multiples may not be suitable for comparison.
How to Read the Reference Price and Its Date
The reference price shown in this guide is historical and dated; it is not a live bid or offer. When assessing Dallah Healthcare, check which trading session the price refers to and whether capital changes, a share split or distributions may affect historical comparisons. Do not confuse the previous closing price with the latest trade or the session average. If market data is delayed, its date should be shown clearly, and a dated figure should not be used to infer a new daily trend.
Building Scenarios Instead of Predicting a Specific Price
Three scenarios can be used to study Dallah Healthcare: improving business conditions, conditions remaining unchanged, and a decline in demand or margins. For each scenario, define measurable assumptions, such as sales volume, input costs or financing expenses, and compare the results with published financial statements when available. Do not set a price target without a valuation model and documented inputs, or present the positive scenario as an expected outcome. The purpose is to understand how sensitive an investment may be to new information.
Checklist Before Making an Investment Decision
Before trading Dallah Healthcare shares, confirm ticker 4004, the company’s identity and the price date; read the latest material disclosure, financial results and auditor’s notes, if available. Distinguish GoFinsa’s research rating from whether the investment suits your personal circumstances. Set your investment horizon, assess your tolerance for loss and consider your portfolio’s exposure to the healthcare sector. Review broker fees and the type of financial instrument: owning shares directly differs from trading derivatives or contracts for difference, which may carry additional risks.
أسئلة شائعة عن الشركة
What is Dallah Healthcare’s stock ticker?
Its ticker on the Saudi Exchange is 4004.
Which sector does Dallah Healthcare belong to?
The stock belongs to the healthcare sector.
Is the GoFinsa rating a buy recommendation?
No. The rating is an analytical tool; it is not a personal investment recommendation or a guarantee of future performance.